Hypothalamic projections to locus coeruleus neurons in rat brain.
Locus coeruleus (LC) neurons respond to autonomic and visceral stimuli and discharge in parallel with peripheral sympathetic nerves. The present study characterized the synaptic organization of hypothalamic afferents with catecholaminergic neurons in the LC using electron microscopy. Peroxidase labeling of axon terminals that were anterogradely labeled from the paraventricular nucleus (PVN) was combined with gold-silver labeling of tyrosine hydroxylase in the LC. Approximately 19% of the anterogradely labeled axon terminals formed synaptic specializations with tyrosine hydroxylase-immunoreactive dendrites in the LC. Retrograde transport from the LC combined with immunocytochemical detection of enkephalin and corticotropin-releasing factor (CRF) suggested that most of the LC-projecting PVN neurons (30%) were CRF immunoreactive and few (2%) were enkephalin immunoreactive. Finally, dual retrograde tracing from the LC and median eminence revealed that PVN neurons that project to the LC are a population distinct from that projecting to the median eminence. The present data suggest that a population of hypothalamic neurons is poised to directly modulate the activity of LC neurons and may integrate autonomic responses in brain by influencing LC neurons. Moreover, PVN neurons that use CRF as a neurohormone are distinct from those that use CRF as a neuromodulator to impact on the LC.
Reyes
Beverly A S
BA
Department of Neurosurgery, Farber Institute for Neurosciences, Thomas Jefferson University, 900 Walnut Street, Suite 400, Philadelphia, PA 19107, USA. bsr103@jefferson.edu
Valentino
Rita J
RJ
Xu
Guangping
G
Van Bockstaele
Elisabeth J
EJ
D000818:Animals; D001341:Autonomic Nervous System / Q000378:metabolism / Q000648:ultrastructure; D001710:Biotin / Q000031:analogs & derivatives; D002395:Catecholamines / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D003712:Dendrites / Q000378:metabolism / Q000648:ultrastructure; D003911:Dextrans; D004745:Enkephalins / Q000378:metabolism; D007150:Immunohistochemistry; D008125:Locus Coeruleus / Q000378:metabolism / Q000648:ultrastructure*; D008297:Male; D008473:Median Eminence / Q000378:metabolism / Q000648:ultrastructure; D046529:Microscopy, Electron, Transmission; D009434:Neural Pathways / Q000378:metabolism / Q000648:ultrastructure*; D009474:Neurons / Q000378:metabolism / Q000648:ultrastructure*; D018377:Neurotransmitter Agents / Q000378:metabolism; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism / Q000648:ultrastructure*; D010835:Phytohemagglutinins; D017729:Presynaptic Terminals / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D013569:Synapses / Q000378:metabolism / Q000648:ultrastructure*; D009435:Synaptic Transmission / Q000502:physiology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D018998:Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate
D002395:Catecholamines; D003911:Dextrans; D004745:Enkephalins; D018377:Neurotransmitter Agents; D010835:Phytohemagglutinins; D018998:Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate; C076397:biotinylated dextran amine; C100156:leukoagglutinins, plants; C062844:wheat germ agglutinin-apohorseradish peroxidase conjugate gold complex; D001710:Biotin; D003346:Corticotropin-Releasing Hormone; D014446:Tyrosine 3-Monooxygenase